OPKO Health Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, OPKO Health stock has a consensus rating of "Buy" and an average price target of $4.38. The average 1-year stock price forecast is 188.16% higher than the current stock price, while the lowest is $3.00 (+97.37%) and the highest is $8.50 (+459.21%).

Price Target: $4.38 (+188.16%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.00	$4.38	$3.00	$8.50
Change	+97.37%	+188.16%	+97.37%	+459.21%

Analyst Ratings

The average analyst rating for OPKO Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	3	3	3	2	2	2
Hold	2	2	2	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $3	Buy	Reiterates	$3	+97.37%	Jun 15, 2026
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $3	Buy	Reiterates	$3	+97.37%	May 26, 2026
Michael Petusky Barrington	Barrington	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Apr 29, 2026
Unknown Analyst Ladenburg Thalmann & Co. No rating	Ladenburg Thalmann & Co.	Buy Reiterates $3	Buy	Reiterates	$3	+97.37%	Feb 27, 2026

Financial Forecast

Revenue This Year

536.88M

from 606.88M

-11.53%

from 606.88M

Revenue Next Year

565.83M

from 536.88M

5.39%

from 536.88M

EPS This Year

-0.38

from -

EPS Next Year

-0.32

from -0.38

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.77B	1.00B	863.50M	713.14M	606.88M	536.88M
Revenue Growth	23.64%	-43.42%	-14.01%	-17.41%	-14.90%	-11.53%
Operating Income	-14.46M	-246.12M	-158.06M	-272.36M	-218.99M	-211.88M
Net Income	-30.14M	-328.41M	-188.86M	-53.22M	-225.68M	-226.87M
EPS	-	-	-	-	-	-0.38
Free Cash Flow	-235.06M	250.37M	16.65M	-128.80M	-131.25M	-112.00M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	546.3M
Avg	536.9M
Low	527.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-10.0%
Avg	-11.5%
Low	-13.1%

EPS Forecast

EPS	2026	2027	2028
High	-0.38
Avg	-0.38
Low	-0.38

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-